CIK: 1531178 - Address: C/O Xeris Biopharma Holdings, Inc., 1375 West Fulton Street, Suite 1300, Chicago, IL 60607
5 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/9/23 18:57
8/9/23
XERSXeris Biopharma Holdings, Inc.DEHealthDrugPharmaceutical PreparationsEdick Paul RILDOSee RemaP242.3801002,321D
12/14/22 16:11
12/13/22
XERSXeris Biopharma Holdings, Inc.DEHealthDrugPharmaceutical PreparationsEdick Paul RILDOSee RemaP291.4502011,561D
5/13/22 16:19
5/12/22
XERSXeris Biopharma Holdings, Inc.DEHealthDrugPharmaceutical PreparationsEdick Paul RILDOSee RemaP1401.40010071,541D
11/16/21 16:25
11/15/21
XERSXeris Biopharma Holdings, Inc.DEHealthDrugPharmaceutical PreparationsEdick Paul RILDOSee RemaP462.280202841I
11/12/21 17:09
11/11/21
XERSXeris Biopharma Holdings, Inc.DEHealthDrugPharmaceutical PreparationsEdick Paul RILDOSee RemaP4162.08020032821D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact